Clinical Trial Update: A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating a heterologous protein prime with an MVA boost therapeutic vaccine candidate for chronic Hepatitis B, currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepatitis B therapeutic vaccine candidate (heterologous protein prime/MVA boost)

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Chronic Hepatitis B | Phase 1 | Status: RECRUITING